Bocidelpar

(Synonyms: ASP0367; MA-0211)
Kundenbewertung

Based on 1 Customer Validation

Bocidelpar (ASP0367; MA-0211) is a selective, orally active PPARδ modulator. Bocidelpar activates the PPARδ downstream signaling pathway, upregulates the expression of target genes such as ABCA1 and ACAA2. Bocidelpar then promotes fatty acid oxidation (FAO) and mitochondrial biogenesis, and improves mitochondrial dysfunction. Bocidelpar can improve mitochondrial biogenesis and function in muscle cells. Bocidelpar is mainly used in the study of mitochondrial dysfunction diseases such as primary mitochondrial myopathy (PMM) and Duchenne muscular dystrophy (DMD).

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

  • Reinheit: 98.08%
  • CAS. Nr.: 2095128-20-2
  • Formel: C25H27F3N2O3
  • Molecular Weight:460.49
  • Speicherung:
    Powder   -20°C, 3 years , 4°C, 2 years ; In solvent   -80°C, 6 months , -20°C, 1 month
  • Biologische Aktivität
  • Chemical Information
  • Lösungsmittel & Löslichkeit
  • Reinheit & Dokumentation
  • Verweise
  • Help & FAQs

Alle PPAR Isoform-spezifische Produkte anzeigen

More
100 mg

Angebot einholen Auf Lager

Please select quantity
Amount: USD 0.00